Logo of Anagenics (ASX:AN1)Latest Anagenics (ASX:AN1) News

Page 2
Page 2 of 2

Anagenics’ Bouf Haircare Launch Surpasses $500K in First Week, Unlocking Long-Term Royalties

Anagenics Limited’s proprietary hair regrowth technology powers the newly launched Bouf Haircare brand, which has achieved over $500,000 in sales in its first week, setting the stage for a lucrative royalty stream.
Victor Sage
4 June 2025

Anagenics Posts Earnings Turnaround in 3Q25 After Restructure and Signs $4.4m Royalty Deal

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.
Victor Sage
5 May 2025

Anagenics Restructures, Issues Shares to FOS Capital, Eyes Growth Path

Anagenics Limited has completed a significant restructuring to simplify operations and issued 35 million shares to FOS Capital as part of this process. The company confirms its going concern status and outlines plans for organic and acquisitive growth over the next year.
Victor Sage
2 May 2025

Anagenics Returns to Profitability with $138k Net Profit in 3Q25

Anagenics Limited has reported a net profit before tax of $138,000 for the quarter ended March 31, 2025, marking a significant turnaround following recent restructuring efforts. Despite a temporary revenue setback due to a warehousing transition, the company’s operating cash flow improved markedly.
Victor Sage
2 May 2025

Anagenics Navigates Q3 2025 Cash Outflows with $1.79M Loan Facilities

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.
Ada Torres
1 May 2025

Anagenics Cuts Costs Sharply, Narrows Cash Outflow in Q2 FY25

Anagenics reports a marked reduction in operating cash outflow and expenses following a strategic restructuring, setting the stage for improved financial stability in the coming quarter.
Victor Sage
10 Feb 2025

Anagenics Cuts Costs Sharply, Eyes Profitability in FY25 Second Half

Anagenics Limited reports a marked reduction in cash outflows and operating costs following a strategic restructuring, with full benefits expected in the latter half of FY2025. Despite divesting Face Medi, core cosmetics sales remain steady.
Victor Sage
31 Jan 2025